盈趣科技(002925.SZ):部分募投項目結項並將節餘募集資金永久補充流動資金
格隆匯 1 月 22日丨盈趣科技(002925.SZ)公佈,公司於2021年1月21日召開的第四屆董事會第六次會議和第四屆監事會第六次會議,審議通過了《關於首次公開發行股票部分募投項目結項並將節餘募集資金永久補充流動資金的議案》,鑑於公司部分募投項目已實施完畢,並已達到預定可使用狀態,為了提高節餘募集資金使用效率,實現公司和股東利益最大化,同意公司將首次公開發行股票部分募投項目結項並將節餘募集資金3.12億元(含投資收益、利息收入,具體金額按轉出當日賬户實際餘額為準)永久補充流動資金。上述議案尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.